TROP2-directed antibody–drug conjugate; the monoclonal antibody binds TROP2 on tumor cells, is internalized, and releases a camptothecin-class topoisomerase I–inhibiting payload causing DNA replication stress, single-strand breaks, and apoptosis (with potential bystander effect).